NCT02060409View on ClinicalTrials.gov

Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome

CompletedOBSERVATIONAL
Enrollment

58

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

February 28, 2014

Conditions
Myelodysplastic Syndrome
Interventions
GENETIC

spliceosome

spliceosome mutations

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT02060409 - Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter